Continuity Biosciences backs Joseph DeSimone PinPrint’s unique 3D printed microneedle tech
US-based biotechnology company Continuity Biosciences has invested in 3D printed microneedle technology specialist PinPrint to expand its focus from therapeutic delivery into aesthetic and cosmetic applications. Designed to deliver vaccines and active agents intradermally, PinPrint’s microneedle patches offer a potential alternative to traditional injections. With this investment, Continuity aims to enhance its capabilities in the […]
US-based biotechnology company Continuity Biosciences has invested in 3D printed microneedle technology specialist PinPrint to expand its focus from therapeutic delivery into aesthetic and cosmetic applications. Designed to deliver vaccines and active agents intradermally, PinPrint’s microneedle patches offer a potential alternative to traditional injections. With this investment, Continuity aims to enhance its capabilities in the […]
